Creoptix Company

Creoptix is a private company headquartered in Wädenswil, near Zurich, Switzerland, with a US office in the Boston area. Creoptix focuses on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research. Based on its proprietary sensor and microfluidics technology, the Creoptix® WAVEsystem provides exceptionally high sensitivity and resolution to study real-time biological interactions involving small molecules, peptides, membrane proteins, biologics, and other molecules even in biofluids like undiluted serum or plasma. Engineered around the proprietary Grating-Coupled Interferometry (GCI) technology, the Creoptix® WAVEsystem delivers high-quality kinetic data across a broader range of samples than traditional SPR equipment.

Invests into

Investors

Connections

Total Funding: 11295683
Founded Date: 2009-01-01
Industry: Gravimetry
Employee Number: 11-50
Last Funding Date: 2019-09-30
Funding Status: private
Headquarters: Wadenswil,Zurich,Switzerland,Europe
Super Industry: Quantum Sensing
Funding Stage: M&A
Funding Total Value: 11000000
Last Funding Total Usd: 8018764
Last Funding Total Currency: CHF
Last Funding Total Value: 8000000
Founders: Kaspar Cottier
Phone Number: +41 44 533 26 60
Register and Claim Ownership